The bone densitometers market comprises a wide range of medical equipment used for measuring bone mineral density and bone mass in areas like osteoporosis screening, diagnosis, and monitoring of therapy. Bone densitometer equipment performs dual-energy X-ray absorptiometry (DXA) scans to assess bone health by comparing an individual's bone mineral density to that of a young healthy adult. The global bone densitometer market growth can be attributed to the increasing prevalence of osteoporosis and a growing geriatric population.

The Global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030.

Key Takeaways
Key players operating in the bone densitometers market are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare dominates the market with over 30% share owing to its wide portfolio ofDXA bone densitometer systems. The increasing prevalence of osteoporosis disorders globally is generating high demand for bone mass measurement equipment. As per International Osteoporosis Foundation, over 50 million Americans have osteoporosis or low bone mass. Technological innovations are inducing portability, accuracy and reduced radiation dosage in bone densitometer equipment which is further supporting market growth.

Market trends
Centralized bone densitometry testing is gaining popularity globally. Many diagnostic centers and specialized clinics are investing in high-end bone densitometry systems instead of desktop models for better utilization. Manufacturers are developing software for automated fracture risk assessment from bone mineral density scans to aid clinical decision making.

Market Opportunities
point-of-care or portable bone density testing devices are witnessing high demand especially for community hospitals and ambulatory care settings. Introduction of latest generation DXA systems with 3D bone texture analysis and body composition assessment beyond bone mineral density are expected accelerate market revenues. Rising health standards in developing nations represent an untapped market opportunity for bone densitometry device makers.

Impact of COVID-19 on Bone Densitometers Market Growth

The COVID-19 pandemic has significantly impacted the growth of the global bone densitometers market. During the initial phases of the pandemic, various restrictions were imposed worldwide which led to the closure of non-emergency healthcare facilities including diagnostic centers. This adversely affected the demand for bone densitometry procedures globally. With people focusing more on COVID prevention and hospitals overwhelmed with coronavirus infected patients, there was a notable decline in the number of osteoporosis and fracture risk assessment scans conducted using bone densitometers.

As the pandemic progressed, healthcare systems started adapting to the new normal. Telehealth and virtual consulting saw increased adoption. However, physical distancing norms continued to hamper the flow of patients to diagnostic centers. In many countries, routine screening programs for osteoporosis were temporarily suspended to reduce exposure. This led to delayed diagnosis and management of osteoporosis. The sales of bone densitometers also declined during this period due to the fall in demand.

Now, with vaccination drives in progress and governments easing restrictions, the bone densitometers market is gradually recovering. Healthcare facilities are resuming non-COVID services while following necessary safety protocols. Greater focus is being placed on clearing backlogs and screening high-risk individuals. New opportunities are emerging in the areas of teleconsultation and portable bone densitometry devices. Market players are actively developing solutions catering to the post-pandemic healthcare landscape. If managed well, the long-term impact of COVID-19 on this market is expected to be moderate with steady growth returning in the coming years.

Geographical Regions with Highest Value Share in Bone Densitometers Market

North America has been dominating the global bone densitometers market and accounted for the highest share in terms of value in recent years. This can be primarily attributed to the region's advanced healthcare infrastructure and rising demand for osteoporosis diagnosis and management. The U.S. represents the largest market for bone densitometers within North America driven by factors like growing aging population, increased incidence of osteoporosis and fractures, and favorable reimbursements.

Coming a close second is Western Europe which has also witnessed significant uptake of bone densitometers across countries like Germany, U.K, France and Italy. Rising public health awareness regarding osteoporosis, favorable government initiatives, and presence of top market players have boosted the adoption of bone densitometry procedures in this region over time.

Fastest Growing Region in Bone Densitometers Market

Asia Pacific region holds strong growth potential for bone densitometers market and is identified as the fastest growing regional market globally. Burgeoning geriatric population, increasing healthcare expenditures, rising public health significance of osteoporosis especially in China and Japan are some key factors fueling the demand.

Growing medical tourism, availability of low-cost treatment options and manufacturing hubs, supportive government policies as well as expanding healthcare infrastructure are attracting major players to tap into opportunities in Asia Pacific countries. Continuous technological advancements and innovative product launches are also facilitating the market penetration. All these factors are anticipated to drive above-average growth rates in Asia Pacific compared to developed Western markets over the coming years.